TY - JOUR T1 - CelLEVITAS: Label-free rapid sorting and enrichment of live cells via magnetic levitation JF - bioRxiv DO - 10.1101/2020.07.27.223917 SP - 2020.07.27.223917 AU - Elliot K. Chin AU - Colin A. Grant AU - Mehmet Giray Ogut AU - Bocheng Cai AU - Naside Gozde Durmus Y1 - 2020/01/01 UR - http://biorxiv.org/content/early/2020/07/29/2020.07.27.223917.abstract N2 - Sorting methods that remove non-viable cells and debris, while retaining a high yield of viable cells, are crucial for many applications in biotechnology, genomics, tissue engineering and medicine. However, a significant challenge is gentle sorting of these different cell states based on very minute differences in density and magnetic signatures, without relying on any labels, tags or markers. Here, a new magnetic levitation-based technology, CelLEVITAS, is developed for the label-free sorting and enrichment of live cells. This work reports the first use of magnetic levitation for sorting of viable and non-viable cells within a microfluidic device and demonstrates extremely effective removal of dead cells and debris from heterogeneous samples. First, the levitation conditions for separating viable and non-viable cells under a magnetic field were fine-tuned. Levitation trajectories of live and dead cell states were then monitored in real-time, as cells magnetically focused to their corresponding levitation bands. CelLEVITAS successfully sorted and enriched live cells from a variety of input cell concentrations (100-200,000 cells/mL) and a variety of input purities (10-50%) into consistently high output purities (>80%). This method is sensitive, does not impair cell viability during sorting, and significantly increases the input sample viability up to 7-fold. Overall, this new magnetic levitation-based sorting strategy drastically reduces the processing time to a single-step, 30-minute sorting protocol and eliminates the manual pre-processing and labeling steps that are required for traditional flow cytometry techniques.Competing Interest StatementN.G.D is a co-founder of and has an equity interest in Levitas Bio, Inc., a company that develops new biotechnology tools for cell sorting and diagnostics. Her interests were viewed and managed in accordance with the conflict of interest policies. ER -